- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Stem Cell Litigants No Stranger to Scientific Limelight
25 August 2010 10:39 am
A day after the Justice Department said it plans to appeal the injunction that suspended federal funding for embryonic stem cell research, more details have emerged on the scientists who won this round. James Sherley, a stem cell researcher at the Boston Biomedical Research Institute in Watertown, Massachusetts, staged a hunger strike in 2007 when the Massachusetts Institute of Technology (MIT) denied him tenure. Sherley said the decision was based on racism. When Sherley was ultimately dismissed, an MIT colleague, Frank Douglas, resigned in protest over how the university handled the case.
Theresa Deisher is the founder of AVM Biotechnology in Seattle, Washington. She worked for several biotechnology companies before founding AVM in 2007, receiving plaudits from some activists for ethical stem cell work. According to the Los Angeles Times, she told Seattle police in 2008 that she was being harassed by former colleagues who blamed her for releasing information that the company was being investigated by the Securities and Exchange Commission. The AVM Web site includes a number of interviews and opinion pieces in which she criticizes research using embryos or fetal tissue, including for example, vaccines based on fetal cells.
See our complete coverage of this issue.